{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:39:39Z","timestamp":1772804379615,"version":"3.50.1"},"reference-count":10,"publisher":"FapUNIFESP (SciELO)","issue":"6 suppl 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Bras. Dermatol."],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:p>The paradoxical adverse effects of tumor necrosis factor-alpha (TNF-alpha) antagonists have been described frequently as a result of the widespread use of these drugs. Among the TNF-alpha blocking agents, few reports exist relating the use of adalimumab in cutaneous sarcoidosis, although all of them show good results. More recently, sarcoidosis onsets have been reported with various TNF-alpha inhibitors. The current case is, to our knowledge, the first to describe the exacerbation of cutaneous lesions of sarcoidosis treated with adalimumab.<\/jats:p>","DOI":"10.1590\/abd1806-4841.20132487","type":"journal-article","created":{"date-parts":[[2014,1,30]],"date-time":"2014-01-30T19:47:31Z","timestamp":1391111251000},"page":"26-28","source":"Crossref","is-referenced-by-count":18,"title":["Exacerbation of recalcitrant cutaneous sarcoidosis with adalimumab - a paradoxical effect? A case report"],"prefix":"10.1590","volume":"88","author":[{"given":"Guida","family":"Santos","sequence":"first","affiliation":[{"name":"Centro Hospitalar de Lisboa Central"}]},{"given":"Lourdes Emerenciano","family":"Sousa","sequence":"additional","affiliation":[{"name":"Centro Hospitalar de Set\u00fabal,  Portugal"}]},{"given":"Alexandre Miguel Bruno Lopes","family":"Jo\u00e3o","sequence":"additional","affiliation":[{"name":"Centro Hospitalar de Lisboa Central,  Portugal"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1590\/S0365-05962007000600010","article-title":"Noninfectious granulomas: sarcoidosis","volume":"82","author":"Daldon PE","year":"2007","journal-title":"An Bras Dermatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1586\/eci.09.18","article-title":"Paradoxical adverse effects of anti-TNF-alpha treatmentonset or exacerbation of cutaneous disorders","volume":"5","author":"Viguier M","year":"2009","journal-title":"Expert Rev Clin Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2515\/therapie\/2011014","article-title":"Sarco\u00efdosis and anti-TNFa paradoxical class effect? Analysis of the French Pharmacovigilance System database and literature review","volume":"66","author":"Javot L","year":"2011","journal-title":"Therapie"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000275676","article-title":"Cutaneous sarcoidosis occurring during anti-TNF-alpha treatment: report of two cases","volume":"220","author":"Dhaille F","year":"2010","journal-title":"Dermatology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2147\/TCRM.S967","article-title":"Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis","volume":"4","author":"Callejas-Rubio JL","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000221005","article-title":"Refractory chronic cutaneous sarcoidosis responsive to dose escalation of TNF-alpha antagonists","volume":"219","author":"Thielen AM","year":"2009","journal-title":"Dermatology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1365-2230.2010.03829.x","article-title":"Recalcitrant cutaneous sarcoidosis responding to adalimumab but not to etanercept","volume":"35","author":"Field S","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/archdermatol.2011.307","article-title":"Successful treatment of lupus pernio with adalimumab","volume":"147","author":"Judson MA","year":"2011","journal-title":"Arch Dermatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000328796","article-title":"Disfiguring annular sarcoidosis improved by adalimumab","volume":"3","author":"Kaiser CA","year":"2011","journal-title":"Case Rep Dermatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jaad.2005.02.023","article-title":"Ulcerative cutaneous sarcoidosis responding to adalimumab","volume":"53","author":"Philips MA","year":"2005","journal-title":"J Am Acad Dermatol"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abd\/v88n6s1\/0365-0596-abd-88-06-s1-0026.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:41Z","timestamp":1747666841000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0365-05962013000800026&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":10,"journal-issue":{"issue":"6 suppl 1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0365-05962013000800026"],"URL":"https:\/\/doi.org\/10.1590\/abd1806-4841.20132487","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}